Spearhead Bio pioneers in native genome engineering, enabling precision agricultural trait integration.
Spearhead Bio has raised $305K in total funding. The most recent round was Grant. The last funding was announced in July 2025.
Spearhead Bio's investors include National Science Foundation, BioSTL, Danforth Technology Company, ROVAQ Ventures, Hjelle Consulting Group.
Spearhead Bio is headquartered in St Louis, United States.
Spearhead Bio pioneers in native genome engineering, enabling precision agricultural trait integration.
Spearhead Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spearhead Bio — Funding & Investors." VCBacked, July 14, 2025, https://www.vcbacked.co/company/spearhead-bio. Accessed September 30, 2026.
VCBacked. (2025). Spearhead Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/spearhead-bio
{{cite web |title=Spearhead Bio — Funding & Investors |url=https://www.vcbacked.co/company/spearhead-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated